The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The state-of-the-art facility is expected to be commissioned over the next three years
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
The move strengthens GBL’s clinical-stage presence in the United States
Patients with BRCA mutations often face aggressive disease and poor prognosis
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
The combination also outperformed chemotherapy on another important secondary endpoint
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
Subscribe To Our Newsletter & Stay Updated
